Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Xalkori 250 mg hard capsules

Active Ingredient:
crizotinib
Company:  
Pfizer Limited See contact details
ATC code: 
L01ED01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Chat Online HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Xalkori (crizotinib) Patient Information Booklet including a Patient Alert Card

This booklet is intended for patients who have been prescribed XALKORI (crizotinib). The patient alert card shown in the booklet is to help patients understand the risks associated with Xalkori, and remind them to seek immediate medical attention if they experience any listed signs and symptoms

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161